(19)
(11) EP 4 824 282 A1

(12)

(43) Date of publication:
21.10.2026 Bulletin 2026/43

(21) Application number: 24846796.1

(22) Date of filing: 16.12.2024
(51) International Patent Classification (IPC): 
C12Q 1/6869(2018.01)
C12Q 1/6806(2018.01)
(52) Cooperative Patent Classification (CPC):
C12Q 1/6806; C12Q 1/6869
 
C-Sets:
  1. C12Q 1/6806, C12Q 2535/122, C12Q 2565/631, C12Q 2521/131, C12Q 2521/125, C12Q 2525/117;
  2. C12Q 1/6869, C12Q 2565/631, C12Q 2521/131, C12Q 2521/125, C12Q 2525/117;

(86) International application number:
PCT/US2024/060408
(87) International publication number:
WO 2025/129193 (19.06.2025 Gazette 2025/25)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 15.12.2023 US 202363610706 P
15.12.2023 US 202363610736 P

(71) Applicant: New England Biolabs, Inc.
Ipswich, MA 01938-2723 (US)

(72) Inventors:
  • SALEH, Lana
    Ipswich, MA 01938 (US)
  • PYLE, Jesse, D.
    Ipswich, MA 01938 (US)
  • LUND, Sean
    Ipswich, MA 01938 (US)
  • O'TOOLE, Katherine, H.
    Ipswich, MA 01938 (US)

(74) Representative: Mathys & Squire 
32 London Bridge Street The Shard
London SE1 9SG
London SE1 9SG (GB)

   


(54) GLYCOSYLTRANSFERASES AND RELATED METHODS